XML 40 R29.htm IDEA: XBRL DOCUMENT v3.25.4
Fair Value Measurements and Investments (Tables)
3 Months Ended
Dec. 31, 2025
Fair Value Disclosures [Abstract]  
Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis
Assets and Liabilities Measured at Fair Value on a Recurring Basis
 Fair Value Measurements
Using Inputs Considered as
 Level 1Level 2
 December 31,
2025
September 30,
2025
December 31,
2025
September 30,
2025
 (in millions)
Assets
Cash equivalents and restricted cash equivalents:
Money market funds
$12,272 $13,760 $ $— 
Investment securities:
Marketable equity securities
428 411  — 
U.S. government-sponsored debt securities
 — 180 305 
U.S. Treasury securities
1,517 2,116  — 
Other current and non-current assets:
Money market funds
25 28  — 
Derivative instruments
 — 83 62 
Total $14,242 $16,315 $263 $367 
Liabilities
Accrued compensation and benefits:
Deferred compensation liability
$300 $268 $ $— 
Accrued and other liabilities:
Derivative instruments
 — 230 319 
Total $300 $268 $230 $319 
Schedule of Amortized Cost, Gross Unrealized Gains and Losses, and Fair Value of Debt Securities
The amortized cost, gross unrealized gains and losses and fair value of debt securities were as follows:
December 31, 2025
Amortized
Cost
Gross UnrealizedFair
Value
GainsLosses
(in millions)
U.S. government-sponsored debt securities$179 $$— $180 
U.S. Treasury securities1,504 13 — 1,517 
Total$1,683 $14 $ $1,697 
September 30, 2025
Amortized
Cost
Gross UnrealizedFair
Value
GainsLosses
(in millions)
U.S. government-sponsored debt securities$304 $$— $305 
U.S. Treasury securities2,101 15 — 2,116 
Total$2,405 $16 $— $2,421 
Schedule of Debt Securities Classified by Contractual Maturity Date
The stated maturities of debt securities were as follows:
December 31,
2025
 (in millions)
Due within one year$1,341 
Due after one year through five years
356 
Total$1,697 
Schedule of Non-Marketable Equity Securities
The following table summarizes the Company’s non-marketable equity securities held as of period end that were accounted for using the fair value measurement alternative:
December 31,
2025
September 30,
2025
(in millions)
Initial cost basis
$714 $711 
Adjustments:
Upward adjustments
567 564 
Downward adjustments, including impairment
(219)(219)
Carrying amount
$1,062 $1,056 
Unrealized gains and losses of the Company’s non-marketable equity securities held as of period end that were accounted for using the fair value measurement alternative were as follows:
Three Months Ended
December 31,
20252024
(in millions)
Upward adjustments$3 $— 
Downward adjustments, including impairment
$ $(91)